MaxCyte offers its platform technology in three scalable transfection systems, the MaxCyte STX, the MaxCyte VLX and the MaxCyte GT. All of our instruments use MaxCyte's proprietary flow electroporation technology for truly scalable, large volume transient transfection. The MaxCyte® STX™ leads the way in high performance, large volume transfection, enabling gram scale antibody and protein production as well as a wide array of cost and time effective cell-based assays. The MaxCyte® VLX™ fulfills the needs for extremely large volume transfection, able to transfect as many as 2x1011 cells in less than 30 minutes. The MaxCyte® GT™ is a cGMP-compliant, clinical-grade instrument that enables the development of enhanced gene therapy and cell therapeutics by providing unparalleled consistency, scalability, and cell loading transfection efficiencies.